← Browse by Condition
Medical Condition

kidney transplant

Total Trials
10
Recruiting Now
10
Trial Phases
Phase 4, Phase 3, Phase 2

ClinicalMetric tracks all active clinical trials for kidney transplant sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.

Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.

Frequently Asked Questions — kidney transplant Clinical Trials

How many clinical trials are currently recruiting for kidney transplant?
ClinicalMetric currently tracks 10 actively recruiting clinical trials for kidney transplant, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 10. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for kidney transplant?
kidney transplant research spans Phase 2 (1 trial), Phase 3 (1 trial), Phase 4 (1 trial). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a kidney transplant clinical trial?
Eligibility criteria for kidney transplant trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 2
1
Phase 3
1
Phase 4
1
Top Sponsors
IRCCS Azienda Ospedaliero-Universitaria di Bologna 2 trials
VA Office of Research and Development 1 trial
Paris Translational Research Center for Organ Transplantation 1 trial
University of Kansas Medical Center 1 trial
Vertex Pharmaceuticals Incorporated 1 trial

Recruiting Clinical Trials

NCT06013865 Phase 4
Recruiting
Empagliflozin Treatment in Kidney Transplant Recipients
Enrollment
264 pts
Location
United States
Sponsor
VA Office of Research and Deve...
View Trial →
NCT06794970
Recruiting
Tissue Study on the Chronic Active Humoral Rejection (cAMR) Population of Kidney Transplantation
Enrollment
50 pts
Location
Italy
Sponsor
IRCCS Azienda Ospedaliero-Univ...
View Trial →
NCT07600541
Recruiting
Perceptions of Kidney Transplant Recipients Regarding the Role of Artificial Intelligence in Medicine
Enrollment
1,000 pts
Location
France
Sponsor
Paris Translational Research C...
View Trial →
NCT06794203
Recruiting
Hyperthyroidism as a Potential Predictive of Worse Outcome of Renal Graft
Enrollment
100 pts
Location
Italy
Sponsor
IRCCS Azienda Ospedaliero-Univ...
View Trial →
NCT06640179
Recruiting
Feasibility and Plausible Effectiveness of a Lifestyle Intervention in Kidney Transplant Recipients (HEAL)
Enrollment
60 pts
Location
United States
Sponsor
University of Kansas Medical C...
View Trial →
NCT06832410 Phase 3
Recruiting
An Efficacy, Safety, and Tolerability Study of VX-880 in Participants With Type 1 Diabetes With a Kidney Transplant
Enrollment
10 pts
Location
United States, Canad...
Sponsor
Vertex Pharmaceuticals Incorpo...
View Trial →
NCT06833463
Recruiting
Tacrolimus and Risk Factors for Glucose Metabolism Disorders in Kidney Transplant Patients
Enrollment
120 pts
Location
Poland
Sponsor
Chiesi Poland Sp. z o.o.
View Trial →
NCT07011238
Recruiting
Alloreactive Memory B Lymphocytes and Anti-HLA Sensitization
Enrollment
51 pts
Location
France
Sponsor
University Hospital, Rouen
View Trial →
NCT06919003 Phase 2
Recruiting
Improving Deceased-Donor Kidney Transplant Outcomes Via a Single Intragraft Injection of C1 Esterase Inhibitor (IMPROVE TRIAL)
Enrollment
180 pts
Location
United States
Sponsor
National Institute of Allergy ...
View Trial →
NCT07760402
Recruiting
Effects Of Propofol And Sevoflurane On Plasma Mirna Levels İn Living Kidney Donors
Enrollment
34 pts
Location
Turkey (Türkiye)
Sponsor
University of Gaziantep
View Trial →

Related Conditions

chronic kidney disease (1) kidney diseases (1) hyperthyroidism (1) overweight or obese adults (1) glucose control (1) type 1 diabetes (1)
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology